Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cardiac TTR Amyloidosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT05019027
What this trial is testing

N-of-1 for Beta-Blockers in Cardiac Amyloidosis

Who this might be right for
Cardiac AmyloidosisHeart DiseasesTTR Cardiac Amyloidosis
Weill Medical College of Cornell University 14
Not applicableUnknownNCT06345235
What this trial is testing

New Biomarkers and Plasma Prothrombotic Potential in Cardiac Transthyretin Amyloidosis

Who this might be right for
Transthyretin Amyloidosis
John Paul II Hospital, Krakow 100
Not applicableStudy completedNCT03886155
What this trial is testing

Cardiac Amyloidosis Screening at Trigger Finger Release

Who this might be right for
AmyloidosisTrigger FingerTransthyretin Amyloidosis+1 more
The Cleveland Clinic 107
Not applicableUnknownNCT03098901
What this trial is testing

Radioisotope Scintigraphy to Establish Incidence of Cardiac Amyloidosis Among Patients With Otherwise Unexplained Cardiac Disease

Who this might be right for
Cardiac TTR Amyloidosis
Kaplan Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT05635045
What this trial is testing

Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR

Who this might be right for
Transthyretin Amyloidosis
Columbia University 10
Not applicableLooking for participantsNCT06251778
What this trial is testing

NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on Tafamidis

Who this might be right for
AmyloidosisAmyloidosis CardiacATTR Amyloidosis Wild Type
Paolo Milani 200
Not applicableLooking for participantsNCT07766135
What this trial is testing

Liver and Coagulation Disorders in Cardiac Transthyretin Amyloidosis

Who this might be right for
Transthyretin (TTR) Amyloid CardiomyopathyCardiac AmyloidosisCardiomyopathies+2 more
University of Messina 70
Not applicableStudy completedNCT01623245
What this trial is testing

Prevalence of Transthyretin Amyloidosis in Hypertrophic Cardiomyopathy

Who this might be right for
Cardiac AmyloidosisAmyloidosis in Transthyretin (TTR)Hypertrophic Cardiomyopathy (HCM)
Thibaud Damy 294
Post-approval studies (Phase 4)Active Not RecruitingNCT05489523
What this trial is testing

Safety, Efficacy, and Pharmacokinetics of Tafamidis in Patients With Transthyretin-mediated Amyloidosis Post Orthotopic Heart Transplantation

Who this might be right for
Transthyretin Cardiac Amyloidosis
University of Texas Southwestern Medical Center 25
Large-scale testing (Phase 3)Study completedNCT02319005
What this trial is testing

ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)

Who this might be right for
Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)Amyloidosis, HereditaryAmyloid Neuropathies, Familial+3 more
Alnylam Pharmaceuticals 206
Not applicableNot Yet RecruitingNCT07835867
What this trial is testing

Individualized Exercise Training in Cardiac Amyloidosis

Who this might be right for
Cardiac Amyloidosis
Oregon Health and Science University 60
Testing effectiveness (Phase 2)Looking for participantsNCT07549841
What this trial is testing

Exploratory Study Evaluating the Relevance of [68Ga]Ga-FAPI-46 for Staging and Identifying Progressing Patients With Transthyretin Cardiac Amyloidosis

Who this might be right for
Transthyretin Cardiac Amyloidosis
Nantes University Hospital 40
Not applicableUnknownNCT05938218
What this trial is testing

Virtual Reality Assisted Patient Empowerment: Diagnose ATTR-Amyloidosis And Start Treatment

Who this might be right for
Amyloidosis CardiacVirtual Reality
Heinrich-Heine University, Duesseldorf 60
Not applicableEnrolling By InvitationNCT07398950
What this trial is testing

Prospective Evaluation of Artificial Intelligence-enabled Screening for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Who this might be right for
ATTR Amyloidosis With CardiomyopathyHeart Failure
Yale University 150
Not applicableLooking for participantsNCT04849754
What this trial is testing

Analysis of the Evolution of SUVmax by Quantitative Analysis Method of Bisphosphonate Scintigraphy

Who this might be right for
Cardiac Amyloidosis
GCS Ramsay Santé pour l'Enseignement et la Recherche 30
Testing effectiveness (Phase 2)WithdrawnNCT02627820
What this trial is testing

The Effect of an Antisense Oligonucleotide to Lower Transthyretin (TTR) Levels on the Progression of -Wild-type TTR Involving the Heart

Who this might be right for
Amyloidosis
Brigham and Women's Hospital
Not applicableLooking for participantsNCT06338696
What this trial is testing

Thailand ATTR-CM Registry

Who this might be right for
Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Mahidol University 105
Not applicableUnknownNCT06101108
What this trial is testing

Early Diagnosis of Age-Linked CArdiac TransThyRetin Amyloidosis by Selective Screening in Spinal Stenosis Surgery

Who this might be right for
Transthyretin Amyloid Cardiomyopathy
Philippe Debonnaire 400
Large-scale testing (Phase 3)Active Not RecruitingNCT04153149
What this trial is testing

HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

Who this might be right for
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Alnylam Pharmaceuticals 655
Large-scale testing (Phase 3)Study completedNCT05064839
What this trial is testing

Imaging for the Evaluation of Transthyretin Cardiac Amyloidosis Prevalence of Patients Over 65 Hospitalized in Cardiology Wards (the IMPACT Study)

Who this might be right for
Transthyretin Cardiac Amyloidosis
Poitiers University Hospital 553
Next Page